Artificial intelligence and data science are rapidly changing medical research and treatment. Big data in healthcare alone was estimated to be worth $14 billion in 2017 and is projected to grow to $68 billion by the end of 2025. This creates an ever-growing field for personalized medicine that includes genomics, chronic condition monitoring, diagnosis, and treatment. Using artificial intelligence to predict conditions and respond with customized treatments allows patients and physicians to respond more quickly and precisely.
This panel discusses how novel data processing technologies will shape our healthcare systems and what impact this will have on our future society. It explores current perspectives and approaches from both sides of the Atlantic, where differences in data collection, privacy policies, and healthcare systems present diverse opportunities and challenges. What potential concerns does data-driven healthcare raise with regards to ethics, accessibility, and democratization? How can the US and Germany learn from one another or collaborate on medical innovation and policy responses?